Paul Meier A Man Behind the Method.

• Autores: Kellyn Betts
• Localización: American journal of public health, ISSN 0090-0036, Vol. 102, Nº. 11, 2012, págs. 2026-2029
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • Paul Meier had a profound impact on how clinical trials now evaluate the efficacy of new drugs and treatment methodologies throughout the world. Meier’s tireless promotion of the now-standard practice of randomly assigning patients enrolled in clinical trials to receive either the conventional remedy or the new treatment being evaluated helped ensure its current status as the most rigorous way to gather evidence of a new drug or treatment’s effectiveness. Meier also helped formulate the Kaplan-Meier estimator, which is now the most popular method of estimating clinical trial participant survival. It is one of the most widely cited articles in the medical literature. INSET: Meier´s Recollections of the Salk Polio Vaccine Trial. [ABSTRACT FROM AUTHOR]